INTERNATIONAL PATENT: TRANSTHERA SCIENCES (NANJING), INC., 药捷安康（南京）科技股份有限公司 FILES APPLICATION FOR "NLRP3 INFLAMMASOME INHIBITOR AND USE THEREOF"

GENEVA, Feb. 24 -- TRANSTHERA SCIENCES (NANJING), INC. (Flr 3, Bld 9, Accelerator Phase 2, Biotech And Pharmaceutical Valley, Jiangbei New AreaNanjing, Jiangsu 210032), 药捷安康（南京）科技股份有限公司 (中国江苏省南京市江北新区生物医药谷加速器二期9栋3楼) filed a patent application (PCT/CN2024/110960) for "NLRP3 INFLAMMASOME INHIBITOR AND USE THEREOF" on Aug 09, 2024. With publication no. WO/2025/036275, the details related to the patent application was published on Feb 20, 2025.

Notably, the patent appli...